“…Several studies have shown that such polygenic scores differ between patients and controls, thus providing a useful tool to measure genetic liability to psychosis in independent samples (Bramon, Pirinen, Strange, Lin, & Spencer, ; Derks et al, ; Purcell et al, ; Vassos et al, ). A number of studies have investigated the relationship between endophenotypes and polygenic risk scores for schizophrenia and bipolar disorder (Caseras, Tansey, Foley, & Linden, ; Hall et al, ; Hubbard et al, ; Lencz et al, ; Liu et al, ; McIntosh et al, ; Papiol et al, ; Terwisscha van Scheltinga, Bakker, van Haren, Derks, Buizer‐Voskamp, Boos, et al, ; Terwisscha van Scheltinga, Bakker, van Haren, Derks, Buizer‐Voskamp, Cahn, et al, ; Van der Auwera et al, ; Whalley et al, , , ). However, previous studies used a case‐control design and focused on specific endophenotypes.…”